Canada, Lilly Make Last Pleas In Patent Policy NAFTA Row
Drug manufacturer Eli Lilly & Co. and Canada's government have made their final arguments to a World Bank tribunal over whether decisions by Canadian courts to terminate two of the company's...To view the full article, register now.
Already a subscriber? Click here to view full article